Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

60 Biggest Movers From Yesterday

Published 26/04/2022, 09:58
Updated 26/04/2022, 10:40
© Reuters.  60 Biggest Movers From Yesterday

Gainers

  • Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.
  • ION Geophysical Corporation (NYSE: IO) gained 46.3% to close at $0.6880 on above-average volume.
  • Cango Inc. (NYSE: CANG) shares rose 40.7% to close at $3.32. Cango, last month, reported worse-than-expected Q4 EPS and sales results.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) jumped 40.6% to settle at $1.87 on above-average volume.
  • ERYTECH Pharma S.A. (NASDAQ: ERYP) shares gained 37.7% to close at $1.68. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for hypersensitive ALL in the British Journal of Haematology.
  • Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 37.5% to settle at $3.92.
  • Ardelyx, Inc. (NASDAQ: ARDX) climbed 31.8% to close at $0.9859 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal of the Complete Response Letter for XPHOZAH.
  • GWG Holdings, Inc. (NASDAQ: GWGH) jumped 31.1% to close at $2.99.
  • ImmuCell Corporation (NASDAQ: ICCC) gained 29% to settle at $10.71.
  • ImmuCell recently said it sees preliminary FY22 sales of $21.1 million.
  • Veru Inc. (NASDAQ: VERU) gained 25.8% to close at $14.10. Veru highlighted presentation of Phase 2 Sabizabulin at the 32nd European Congress of Clinical Microbiology & Infectious Diseases.
  • Sunshine Biopharma, Inc. (NASDAQ: SBFM) rose 20.4% to close at $4.01 after the company reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
  • Swvl Holdings Corp. (NASDAQ: SWVL) shares rose 18.6% to close at $7.67 after the company announced its agreement to acquire Volt Lines.
  • Cabaletta Bio, Inc. (NASDAQ: CABA) jumped 18.6% to settle at $1.59.
  • RiceBran Technologies (NASDAQ: RIBT) surged 18.3% to close at $0.6287.
  • iCAD, Inc. (NASDAQ: ICAD) rose 18.2% to close at $3.57.
  • BigBear.ai Holdings, Inc. (NASDAQ: BBAI) gained 18.1% to close at $10.10.
  • AgeX Therapeutics, Inc. (NYSE: AGE) jumped 17.7% to settle at $1.00. AgeX Therapeutics, last month, reported Q4 earnings results.
  • CinCor Pharma, Inc. (NASDAQ: CINC) surged 17.3% to close at $25.48.
  • Aterian, Inc. (NASDAQ: ATER) climbed 16.4% to settle at $5.11.
  • IT Tech Packaging, Inc. (NYSE: ITP) shares rose 16.4% to close at $0.33. IT Tech Packaging, last monthm said Q4 EPS and sales results were higher year over year.
  • INmune Bio, Inc. (NASDAQ: INMB) gained 16.2% to settle at $7.96.
  • Sky Harbour Group Corporation (NASDAQ: SKYH) jumped 16% to close at $9.29.
  • DatChat, Inc. (NASDAQ: DATS) rose 15.7% to close at $1.99.
  • Zymergen Inc. (NASDAQ: ZY) gained 15.2% to settle at $2.05.
  • Dogness (International) Corporation (NASDAQ: DOGZ) gained 15.1% to close at $4.04.
  • PaySign, Inc. (NASDAQ: PAYS) rose 13.5% to settle at $1.93.
  • Silicon Motion Technology Corporation (NASDAQ: SIMO) gained 12.9% to close at $87.02 after Bloomberg reported that the company exploring a potential sale amid takeover interest.
  • PetVivo Holdings, Inc. (NASDAQ: PETV) gained 12.7% to close at $2.22.
  • PS Business Parks, Inc. (NYSE: PSB) climbed 11.8% to close at $187.50 after the company announced it will be acquired by affiliates of Blackstone (NYSE:BX) Real Estate for $7.6 billion.
  • Cenntro Electric Group Limited (NASDAQ: CENN) gained 10.6% to settle at $1.88 after gaining around 7% on Friday.
  • BioLife Solutions, Inc. (NASDAQ: BLFS) rose 9.5% to close at $13.79. Oppenheimer upgraded BioLife Solns from Perform to Outperform and announced a $28 price target.
  • Joby Aviation, Inc. (NYSE: JOBY) jumped 6.8% to close at $5.31.
  • Graphite Bio, Inc. (NASDAQ: GRPH) gained 6.8% to settle at $4.27.
  • Eros STX Global Corporation (NYSE: ESGC) rose 6.7% to close at $2.39.

Losers

  • Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) shares dipped 56.2% to settle at $0.7889 on Monday. Clarus Therapeutics reporetd pricing of upsized underwritten public offering at $1.10 per share.
  • Eliem Therapeutics, Inc. (NASDAQ: ELYM) shares tumbled 55.8% to close at $2.88 on Monday after the company announced the Phase 2a clinical trial of ETX-810 in diabetic peripheral neuropathic pain did not achieve the primary endpoint. The company also announced it elected to delay enrollment of its Phase 2a clinical trials of ETX-155 in major depressive disorder and perimenopausal depression.
  • ToughBuilt Industries, Inc. (NASDAQ: TBLT) fell 44.9% to close at $14.57. ToughBuilt Industries reported a 1-for-150 reverse stock split as part of Nasdaq compliance plan.
  • Avadel Pharmaceuticals plc (NASDAQ: AVDL) dipped 36% to settle at $4.21. Avadel Pharmaceuticals announced interim data from the open-label RESTORE study at the 2022 American Academy of Neurology Annual Meeting.
  • Cypress Environmental Partners, L.P. (NYSE: CELP) fell 34.5% to close at $0.4212 after the company said an affiliate of Argonaut Private Equity has acquired 100% of Cypress’s senior secured debt from the seven existing lenders.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) fell 26.4% to close at $0.3267 on above-average volume.
  • Baosheng Media Group Holdings Limited (NASDAQ: BAOS) fell 25.6% to close at $0.7890.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) dropped 22% to close at $30.50 after the company reported it was informed by the FDA that chemistry, manufacturing, and control issues identified during the FDA's review of its NDA for its AXS-07 product candidate are unresolved.
  • Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) fell 20.5% to close at $0.9620.
  • FingerMotion, Inc. (NASDAQ: FNGR) declined 20.2% to close at $2.10.
  • EuroDry Ltd. (NASDAQ: EDRY) fell 19.1% to close at $32.21. EuroDry recently announced plans to acquire M/V Santa Cruz Bulker for $15.75 million.
  • Pineapple Energy Inc. (NASDAQ: PEGY) dipped 17.1% to settle at $3.35.
  • Brickell Biotech, Inc. (NASDAQ: BBI) fell 17% to settle at $0.2615.
  • Navios Maritime Holdings Inc. (NYSE: NM) dropped 15.4% to close at $3.73.
  • Bone Biologics Corporation (NASDAQ: BBLG) fell 14.8% to settle at $2.02.
  • Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) fell 14.4% to close at $1.94. Vallon Pharmaceuticals shares jumped more than 100% on Friday after the company announced a review of strategic alternatives.
  • China Liberal Education Holdings Limited (NASDAQ: CLEU) dropped 14.1% to close at $1.34.
  • Leju Holdings Limited (NYSE: LEJU) fell 14% to settle at $0.43.
  • COMSovereign Holding Corp. (NASDAQ: COMS) fell 13.9% to settle at $0.3964.
  • Nordic American Tankers Limited (NYSE: NAT) dropped 12.5% to close at $2.44.
  • MedAvail Holdings, Inc. (NASDAQ: MDVL) dipped 12.4% to close at $2.3750.
  • HighPeak Energy, Inc. (NASDAQ: HPK) dropped 11.5% to close at $33.35.
  • Koninklijke Philips N.V. (NYSE: PHG) shares fell 11.3% to close at $26.91. Philips reported a first-quarter FY22 sales growth of 2.6% year-on-year to €3.9 billion.
  • Golden Ocean Group Limited (NASDAQ: GOGL) fell 10.9% to close at $11.66.
  • Cyngn Inc. (NASDAQ: CYN) fell 10% to close at $2.42 after climbing around 27% on Friday. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
  • TradeUP Global Corporation (NASDAQ: TUGC) dipped 7.3% to settle at $9.22.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.